-
Something wrong with this record ?
Novel Benzene-Based Carbamates for AChE/BChE Inhibition: Synthesis and Ligand/Structure-Oriented SAR Study
A. Bak, V. Kozik, D. Kozakiewicz, K. Gajcy, DJ. Strub, A. Swietlicka, S. Stepankova, A. Imramovsky, J. Polanski, A. Smolinski, J. Jampilek,
Language English Country Switzerland
Document type Journal Article
Grant support
LO1305
Ministry of Education of the Czech Republic
APVV-17-0373 and APVV-14-0547
Slovak Research and Development Agency
NLK
Free Medical Journals
from 2000
Freely Accessible Science Journals
from 2000
PubMed Central
from 2007
Europe PubMed Central
from 2007
ProQuest Central
from 2000-03-01
Open Access Digital Library
from 2000-01-01
Open Access Digital Library
from 2007-01-01
Health & Medicine (ProQuest)
from 2000-03-01
ROAD: Directory of Open Access Scholarly Resources
from 2000
PubMed
30934674
DOI
10.3390/ijms20071524
Knihovny.cz E-resources
- MeSH
- Acetylcholinesterase metabolism MeSH
- Principal Component Analysis MeSH
- Benzene chemical synthesis chemistry pharmacology MeSH
- Butyrylcholinesterase metabolism MeSH
- Cholinesterase Inhibitors chemical synthesis chemistry pharmacology MeSH
- Electrophorus MeSH
- Inhibitory Concentration 50 MeSH
- Carbamates chemical synthesis chemistry pharmacology MeSH
- Horses MeSH
- Ligands MeSH
- Probability MeSH
- Drug Design MeSH
- Molecular Docking Simulation MeSH
- Structure-Activity Relationship MeSH
- Animals MeSH
- Check Tag
- Animals MeSH
- Publication type
- Journal Article MeSH
A series of new benzene-based derivatives was designed, synthesized and comprehensively characterized. All of the tested compounds were evaluated for their in vitro ability to potentially inhibit the acetyl- and butyrylcholinesterase enzymes. The selectivity index of individual molecules to cholinesterases was also determined. Generally, the inhibitory potency was stronger against butyryl- compared to acetylcholinesterase; however, some of the compounds showed a promising inhibition of both enzymes. In fact, two compounds (23, benzyl ethyl(1-oxo-1-phenylpropan-2-yl)carbamate and 28, benzyl (1-(3-chlorophenyl)-1-oxopropan-2-yl) (methyl)carbamate) had a very high selectivity index, while the second one (28) reached the lowest inhibitory concentration IC50 value, which corresponds quite well with galanthamine. Moreover, comparative receptor-independent and receptor-dependent structure⁻activity studies were conducted to explain the observed variations in inhibiting the potential of the investigated carbamate series. The principal objective of the ligand-based study was to comparatively analyze the molecular surface to gain insight into the electronic and/or steric factors that govern the ability to inhibit enzyme activities. The spatial distribution of potentially important steric and electrostatic factors was determined using the probability-guided pharmacophore mapping procedure, which is based on the iterative variable elimination method. Additionally, planar and spatial maps of the host⁻target interactions were created for all of the active compounds and compared with the drug molecules using the docking methodology.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19034673
- 003
- CZ-PrNML
- 005
- 20191008105126.0
- 007
- ta
- 008
- 191007s2019 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3390/ijms20071524 $2 doi
- 035 __
- $a (PubMed)30934674
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Bak, Andrzej $u Institute of Chemistry, University of Silesia, Szkolna 9, 40 007 Katowice, Poland. andrzej.bak@us.edu.pl.
- 245 10
- $a Novel Benzene-Based Carbamates for AChE/BChE Inhibition: Synthesis and Ligand/Structure-Oriented SAR Study / $c A. Bak, V. Kozik, D. Kozakiewicz, K. Gajcy, DJ. Strub, A. Swietlicka, S. Stepankova, A. Imramovsky, J. Polanski, A. Smolinski, J. Jampilek,
- 520 9_
- $a A series of new benzene-based derivatives was designed, synthesized and comprehensively characterized. All of the tested compounds were evaluated for their in vitro ability to potentially inhibit the acetyl- and butyrylcholinesterase enzymes. The selectivity index of individual molecules to cholinesterases was also determined. Generally, the inhibitory potency was stronger against butyryl- compared to acetylcholinesterase; however, some of the compounds showed a promising inhibition of both enzymes. In fact, two compounds (23, benzyl ethyl(1-oxo-1-phenylpropan-2-yl)carbamate and 28, benzyl (1-(3-chlorophenyl)-1-oxopropan-2-yl) (methyl)carbamate) had a very high selectivity index, while the second one (28) reached the lowest inhibitory concentration IC50 value, which corresponds quite well with galanthamine. Moreover, comparative receptor-independent and receptor-dependent structure⁻activity studies were conducted to explain the observed variations in inhibiting the potential of the investigated carbamate series. The principal objective of the ligand-based study was to comparatively analyze the molecular surface to gain insight into the electronic and/or steric factors that govern the ability to inhibit enzyme activities. The spatial distribution of potentially important steric and electrostatic factors was determined using the probability-guided pharmacophore mapping procedure, which is based on the iterative variable elimination method. Additionally, planar and spatial maps of the host⁻target interactions were created for all of the active compounds and compared with the drug molecules using the docking methodology.
- 650 _2
- $a acetylcholinesterasa $x metabolismus $7 D000110
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a benzen $x chemická syntéza $x chemie $x farmakologie $7 D001554
- 650 _2
- $a butyrylcholinesterasa $x metabolismus $7 D002091
- 650 _2
- $a karbamáty $x chemická syntéza $x chemie $x farmakologie $7 D002219
- 650 _2
- $a cholinesterasové inhibitory $x chemická syntéza $x chemie $x farmakologie $7 D002800
- 650 _2
- $a racionální návrh léčiv $7 D015195
- 650 _2
- $a Electrophorus $7 D004593
- 650 _2
- $a koně $7 D006736
- 650 _2
- $a inhibiční koncentrace 50 $7 D020128
- 650 _2
- $a ligandy $7 D008024
- 650 _2
- $a simulace molekulového dockingu $7 D062105
- 650 _2
- $a analýza hlavních komponent $7 D025341
- 650 _2
- $a pravděpodobnost $7 D011336
- 650 _2
- $a vztahy mezi strukturou a aktivitou $7 D013329
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Kozik, Violetta $u Institute of Chemistry, University of Silesia, Szkolna 9, 40 007 Katowice, Poland. violetta.kozik@us.edu.pl.
- 700 1_
- $a Kozakiewicz, Dariusz $u Institute of Chemistry, University of Silesia, Szkolna 9, 40 007 Katowice, Poland. dkozakiewicz@us.edu.pl.
- 700 1_
- $a Gajcy, Kamila $u Institute of Chemistry, University of Silesia, Szkolna 9, 40 007 Katowice, Poland. kamila.gajcy@us.edu.pl.
- 700 1_
- $a Strub, Daniel Jan $u Department of Bioorganic Chemistry, Faculty of Chemistry, Wrocław University of Science and Technology, Wyb. Wyspiańskiego 27, 50-370 Wrocław, Poland. daniel.strub@pwr.edu.pl.
- 700 1_
- $a Swietlicka, Aleksandra $u Institute of Chemistry, University of Silesia, Szkolna 9, 40 007 Katowice, Poland. aswietlicka@us.edu.pl.
- 700 1_
- $a Stepankova, Sarka $u Department of Biological and Biochemical Sciences, Faculty of Chemical Technology, University of Pardubice, Studentska 573, 532 10 Pardubice, Czech Republic. sarka.stepankova@upce.cz.
- 700 1_
- $a Imramovsky, Ales $u Institute of Organic Chemistry and Technology, Faculty of Chemical Technology, University of Pardubice, Studentska 573, 532 10 Pardubice, Czech Republic. ales.imramovsky@upce.cz.
- 700 1_
- $a Polanski, Jaroslaw $u Institute of Chemistry, University of Silesia, Szkolna 9, 40 007 Katowice, Poland. jaroslaw.polanski@us.edu.pl.
- 700 1_
- $a Smolinski, Adam $u Department of Energy Saving and Air Protection, Central Mining Institute, Plac Gwarkow 1, 40 166 Katowice, Poland. smolin@gig.katowice.pl.
- 700 1_
- $a Jampilek, Josef $u Division of Biologically Active Complexes and Molecular Magnets, Regional Centre of Advanced Technologies and Materials, Faculty of Science, Palacky University, Slechtitelu 27, 78371 Olomouc, Czech Republic. josef.jampilek@gmail.com. Institute of Neuroimmunology, Slovak Academy of Sciences, Dubravska cesta 9, 84510, Bratislava, Slovakia. josef.jampilek@gmail.com.
- 773 0_
- $w MED00176142 $t International journal of molecular sciences $x 1422-0067 $g Roč. 20, č. 7 (2019)
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/30934674 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20191007 $b ABA008
- 991 __
- $a 20191008105542 $b ABA008
- 999 __
- $a ok $b bmc $g 1451333 $s 1073223
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2019 $b 20 $c 7 $e 20190327 $i 1422-0067 $m International journal of molecular sciences $n Int J Mol Sci $x MED00176142
- GRA __
- $a LO1305 $p Ministry of Education of the Czech Republic
- GRA __
- $a APVV-17-0373 and APVV-14-0547 $p Slovak Research and Development Agency
- LZP __
- $a Pubmed-20191007